Upgrade to SI Premium - Free Trial

Weakness in Intuitive Surgical (ISRG) is A Buying Opportunity - Goldman Sachs

April 19, 2013 12:30 PM
Goldman Sachs lowered its price target on Intuitive Surgical (NASDAQ: ISRG) from $712 to $684 but maintained a Buy rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles